Marco Bruzzone

4.0k citations
136 papers · 1.9k indexed · 1 hit paper · h-index 24

Marco Bruzzone

129 papers receiving 1.9k citations

Hit Papers

Platinum-based neoadjuvant chemotherapy in triple-negativ...3032018202620202023100200300

Peers

Marco Bruzzone
Comparison fields: 5 of 151
  • Cancer Research 413
  • Oncology 707
  • Reproductive Medicine 128
  • Immunology and Allergy 66
  • Process Chemistry and Technology 30
Replace Sarah A. Taylor with:
Sarah A. Taylor United States
Chia‐Hung Chou Taiwan
Ruifang Chen China
D Belpomme France
Yoshiyuki Fujiwara Japan
Daniel Couturier France
Jingyu Chen China
Michael Hayes United States
Yimin Wang China
K. Ulm Germany
Marco Bruzzone relative to Sarah A. Taylor United States Sarah A. Taylor's profile →
Citations per field
00.5×
Sarah A. Taylor · 1×
Citations per year

Countries citing papers authored by Marco Bruzzone

Since Specialization
Citations

This map shows the geographic impact of Marco Bruzzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bruzzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bruzzone more than expected).

Fields of papers citing papers by Marco Bruzzone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Bruzzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bruzzone. The network helps show where Marco Bruzzone may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marco Bruzzone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marco Bruzzone Line = papers co-authored together Marco Bruzzone links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20244
3 20246
4 20240
5 20231
6 202324
7 202261
8 202144
9 202126
10 20211
11 201911
12 20191
13 201812
14 201847
15 201710
16 201717
17 201713
18 201625
19 20151
20
Cisplatin-based combination chemotherapy with or without doxorubicin in advanced epithelial ovarian cancer: 8-year update of a randomized multicentric clinical trial. The Gruppo Oncologico Nord Ovest (GONO).
19923

About Marco Bruzzone

Marco Bruzzone is a scholar working on Cancer Research, Oncology and Polymers and Plastics, having authored 136 papers that have together received 1.9k indexed citations. Recurring topics across this work include Organometallic Complex Synthesis and Catalysis (14 papers), Breast Cancer Treatment Studies (11 papers), Polymer Nanocomposites and Properties (10 papers), Cancer Treatment and Pharmacology (10 papers), Carcinogens and Genotoxicity Assessment (8 papers), HER2/EGFR in Cancer Research (8 papers), Polymer crystallization and properties (8 papers) and Advanced Breast Cancer Therapies (7 papers). The work is most often cited by research in Cancer Research (413 citations), Oncology (707 citations) and Reproductive Medicine (128 citations). Marco Bruzzone has collaborated with scholars based in Italy, Belgium and United States. Frequent co-authors include Marcello Ceppi, Matteo Lambertini, Evandro de Azambuja, Lucia Del Mastro, Francesca Poggio, Noam Pondé, Giovanni La Valle, Elisa Agostinetto, Michael Fenech and Claudia Bolognesi. Their work appears in journals such as ESMO Open, Rubber Chemistry and Technology, European Journal of Cancer, Inorganica Chimica Acta and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026